The company has also launched Elyara, a portfolio of products in regenerative medical aesthetics focused on non-invasive skin and hair restoration
Designed for high-throughput genomic analysis, the laboratory enables accurate, consistent, and scalable testing, delivering high standards of reporting excellence
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs
Discussions focused on digital health, non-communicable diseases, resilient supply chains, medical innovation, and healthcare workforce development
The ISG assessment highlights Indegene’s deep domain expertise, proprietary technology stack, and expanding use of AI and GenAI to drive more integrated, data-led commercial execution across the life sciences value chain
Keeps Halo Pharma to drive independent growth
Dr Mohit Bhandari remotely conducted a complex robotic gastrojejunostomy from Perth using the indigenous SSI Mantra Surgical Robotic System
The company secured new accounts, including ACCESS-PVI trial sites, and aims to strengthen global commercialization efforts
Subscribe To Our Newsletter & Stay Updated
